TransMedics (TMDX) Net Cash Flow Growth (5y) (2023 - 2026)
TransMedics (TMDX) Net Cash Flow Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | TransMedics | 2.54 Bn | 2.08 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.65% |
| Dec 31, 2025 | 51.39% |
| Sep 30, 2025 | 33.13% |
| Jun 30, 2025 | 27.81% |
| Mar 31, 2025 | -50.52% |
| Dec 31, 2024 | 118.92% |
| Sep 30, 2024 | -4.28% |
| Jun 30, 2024 | -18.41% |
| Mar 31, 2024 | -41.02% |
| Dec 31, 2023 | -30.73% |
| Sep 30, 2023 | -94.36% |
| Jun 30, 2023 | 73.27% |
| Mar 31, 2023 | -20.12% |